ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ROQAF Roquefort Therapeutics PLC (QB)

0.06
0.00 (0.00%)
Jun 17 2024 - Closed
Delayed by 15 minutes

Roquefort Therapeutics (QB) Financial Summary

The current ROQAF market cap is 7.75M. The company's latest EPS is GBP -0.0135 and P/E is -3.33.

Year End December 30 2023 202120222023
GBP (£)GBP (£)GBP (£)
Total Revenue 1,0000200k
Operating Income -916k-1.63M-1.93M
Net Income -916k-1.62M-1.75M
Year End December 30 2023 202120222023
GBP (£)GBP (£)GBP (£)
Total Assets 4.56M7.77M6.09M
Total Liabilities 477k561k589k
Total Equity 4.08M7.21M5.5M

Cash Flow

Year End December 30 2023 202120222023
GBP (£)GBP (£)GBP (£)
Operating -516k-1.58M-1.73M
Investing -606k-103k-53k
Financing 2.02M3.1M N/A
Market Cap 7.75M
Price to Earnings Ratio -3.33
Price to Sales Ratio 30
Price to Cash Ratio 10.71
Price to Book Ratio 1.06
Dividend Yield -

Share Statistics

Shares Outstanding 129.15M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -41.97%
52 Week High 0.1034
52 Week Low 0.06
Spread (Intraday) 104.08 (100%)

Company Info

Company Name Roquefort Therapeutics PLC (QB)
Address 85 great portland street
london W1W 7LT
Website https://www.roquefortplc.com
Industry cmp integrated sys design (7373)

Your Recent History